Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$118.07 - $194.18 $15,349 - $25,243
-130 Reduced 6.61%
1,837 $217,000
Q2 2022

Aug 16, 2022

BUY
$117.13 - $176.59 $5,153 - $7,769
44 Added 2.29%
1,967 $281,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $67,403 - $125,281
533 Added 38.35%
1,923 $331,000
Q4 2021

Feb 03, 2022

BUY
$225.82 - $368.51 $313,889 - $512,228
1,390 New
1,390 $353,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.